DELFI (IMAGE)
Caption
New liquid biopsy test called DELFI uses artificial intelligence to detect patients with cancer by identifying altered DNA fragmentation in the blood.
Credit
Carolyn Hruban
Usage Restrictions
None
License
Licensed content